Industry Research Reports
Home > Reports > Service & Software > CAR-T Cell Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
CAR-T Cell Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Service & Software
Published Date: 2025-04-03
Pages: 140 Pages
Report ld: 4648551
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
CAR-T Cell Service Market Size(US$)
CAGR 2025-2031
5.4%
Market Size,2031
USD 1,978
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,443 million
Market Forecast in 2031(Value)
US$ 1,978 million
CAGR
5.4%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for CAR-T Cell Service was estimated to be worth US$ 1375 million in 2024 and is forecast to a readjusted size of US$ 1978 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
CAR-T (Chimeric Antigen Receptor T-cell) therapy is an innovative and personalized form of immunotherapy designed to treat certain types of cancers, particularly blood cancers like leukemia and lymphoma. The development of CAR-T cells involves a complex process that requires several specialized services. A comprehensive CAR-T cell development service covers the entire pipeline from initial consultation and CAR design through to clinical trials and post-approval support. It is tailored to meet the unique needs of each patient's cancer type, the desired target antigen, and the specific requirements of regulatory agencies.
The CAR - T cell service industry is currently experiencing rapid development and faces many opportunities and challenges. Driven by the increasing incidence of cancer and the continuous advancement of technology, the industry has broad development prospects. Technologically, the research and development of new CAR - T cell technologies is accelerating. The industry is committed to improving the efficacy and safety of CAR - T cells in treating solid tumors, such as by adding controllable suicide genes and pro - inflammatory cytokines to the CAR structure. In addition, the exploration of CAR - T cell therapy in the treatment of autoimmune diseases has also become a hot topic, with many clinical trials ongoing. Commercially, there are currently 11 CAR - T cell therapy drugs approved globally, with sales continuing to increase. However, the high price of drugs and the narrow patient population limit the expansion of the market scale. Therefore, reducing costs and expanding the patient population are the main development directions of enterprises. In the future, with the continuous progress of technology and the expansion of application scenarios, the CAR - T cell service industry is expected to achieve greater development and bring more hope to patients with cancer and autoimmune diseases.
This report aims to provide a comprehensive presentation of the global market for CAR-T Cell Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of CAR-T Cell Service by region & country, by Type, and by Application.
The CAR-T Cell Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Cell Service.
MARKET SEGMENTATION
By Company
- Aurigene Pharmaceutical Services Ltd
- Cellipont Bioservices
- ProBio
- Creative Biolabs
- Charles River Laboratories
- Cytiva
- Sino Biological, Inc
- Miltenyi Biotec
- ProMab Biotechnologies, Inc
- Creative Biogene
- BPS Bioscience, Inc
- Reaction Biology
- Cusabio Technology LLC
- Oncodesign Services
- ACROBiosystems
- Kite Pharma, Inc
- sartorius
- WuXi ATU Co
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Development Services
- Manufacturing Services
- Other
Segment by Application
- Clinical Research
- Clinical Treatment
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of CAR-T Cell Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of CAR-T Cell Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of CAR-T Cell Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 CAR-T Cell Service Product Introduction
1.2 Global CAR-T Cell Service Market Size Forecast (2020-2031)
1.3 CAR-T Cell Service Market Trends & Drivers
1.3.1 CAR-T Cell Service Industry Trends
1.3.2 CAR-T Cell Service Market Drivers & Opportunity
1.3.3 CAR-T Cell Service Market Challenges
1.3.4 CAR-T Cell Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global CAR-T Cell Service Players Revenue Ranking (2024)
2.2 Global CAR-T Cell Service Revenue by Company (2020-2025)
2.3 Key Companies CAR-T Cell Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies CAR-T Cell Service Product Offered
2.5 Key Companies Time to Begin Mass Production of CAR-T Cell Service
2.6 CAR-T Cell Service Market Competitive Analysis
2.6.1 CAR-T Cell Service Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by CAR-T Cell Service Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Service as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Development Services
3.1.2 Manufacturing Services
3.1.3 Other
3.2 Global CAR-T Cell Service Sales Value by Type
3.2.1 Global CAR-T Cell Service Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global CAR-T Cell Service Sales Value, by Type (2020-2031)
3.2.3 Global CAR-T Cell Service Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinical Research
4.1.2 Clinical Treatment
4.1.3 Other
4.2 Global CAR-T Cell Service Sales Value by Application
4.2.1 Global CAR-T Cell Service Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global CAR-T Cell Service Sales Value, by Application (2020-2031)
4.2.3 Global CAR-T Cell Service Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global CAR-T Cell Service Sales Value by Region
5.1.1 Global CAR-T Cell Service Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global CAR-T Cell Service Sales Value by Region (2020-2025)
5.1.3 Global CAR-T Cell Service Sales Value by Region (2026-2031)
5.1.4 Global CAR-T Cell Service Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America CAR-T Cell Service Sales Value, 2020-2031
5.2.2 North America CAR-T Cell Service Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe CAR-T Cell Service Sales Value, 2020-2031
5.3.2 Europe CAR-T Cell Service Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific CAR-T Cell Service Sales Value, 2020-2031
5.4.2 Asia Pacific CAR-T Cell Service Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America CAR-T Cell Service Sales Value, 2020-2031
5.5.2 South America CAR-T Cell Service Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa CAR-T Cell Service Sales Value, 2020-2031
5.6.2 Middle East & Africa CAR-T Cell Service Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions CAR-T Cell Service Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions CAR-T Cell Service Sales Value, 2020-2031
6.3 United States
6.3.1 United States CAR-T Cell Service Sales Value, 2020-2031
6.3.2 United States CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
6.3.3 United States CAR-T Cell Service Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe CAR-T Cell Service Sales Value, 2020-2031
6.4.2 Europe CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe CAR-T Cell Service Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China CAR-T Cell Service Sales Value, 2020-2031
6.5.2 China CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
6.5.3 China CAR-T Cell Service Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan CAR-T Cell Service Sales Value, 2020-2031
6.6.2 Japan CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan CAR-T Cell Service Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea CAR-T Cell Service Sales Value, 2020-2031
6.7.2 South Korea CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea CAR-T Cell Service Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia CAR-T Cell Service Sales Value, 2020-2031
6.8.2 Southeast Asia CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia CAR-T Cell Service Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India CAR-T Cell Service Sales Value, 2020-2031
6.9.2 India CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
6.9.3 India CAR-T Cell Service Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Aurigene Pharmaceutical Services Ltd
7.1.1 Aurigene Pharmaceutical Services Ltd Profile
7.1.2 Aurigene Pharmaceutical Services Ltd Main Business
7.1.3 Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Products, Services and Solutions
7.1.4 Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.1.5 Aurigene Pharmaceutical Services Ltd Recent Developments
7.2 Cellipont Bioservices
7.2.1 Cellipont Bioservices Profile
7.2.2 Cellipont Bioservices Main Business
7.2.3 Cellipont Bioservices CAR-T Cell Service Products, Services and Solutions
7.2.4 Cellipont Bioservices CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.2.5 Cellipont Bioservices Recent Developments
7.3 ProBio
7.3.1 ProBio Profile
7.3.2 ProBio Main Business
7.3.3 ProBio CAR-T Cell Service Products, Services and Solutions
7.3.4 ProBio CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.3.5 ProBio Recent Developments
7.4 Creative Biolabs
7.4.1 Creative Biolabs Profile
7.4.2 Creative Biolabs Main Business
7.4.3 Creative Biolabs CAR-T Cell Service Products, Services and Solutions
7.4.4 Creative Biolabs CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.4.5 Creative Biolabs Recent Developments
7.5 Charles River Laboratories
7.5.1 Charles River Laboratories Profile
7.5.2 Charles River Laboratories Main Business
7.5.3 Charles River Laboratories CAR-T Cell Service Products, Services and Solutions
7.5.4 Charles River Laboratories CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.5.5 Charles River Laboratories Recent Developments
7.6 Cytiva
7.6.1 Cytiva Profile
7.6.2 Cytiva Main Business
7.6.3 Cytiva CAR-T Cell Service Products, Services and Solutions
7.6.4 Cytiva CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.6.5 Cytiva Recent Developments
7.7 Sino Biological, Inc
7.7.1 Sino Biological, Inc Profile
7.7.2 Sino Biological, Inc Main Business
7.7.3 Sino Biological, Inc CAR-T Cell Service Products, Services and Solutions
7.7.4 Sino Biological, Inc CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.7.5 Sino Biological, Inc Recent Developments
7.8 Miltenyi Biotec
7.8.1 Miltenyi Biotec Profile
7.8.2 Miltenyi Biotec Main Business
7.8.3 Miltenyi Biotec CAR-T Cell Service Products, Services and Solutions
7.8.4 Miltenyi Biotec CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.8.5 Miltenyi Biotec Recent Developments
7.9 ProMab Biotechnologies, Inc
7.9.1 ProMab Biotechnologies, Inc Profile
7.9.2 ProMab Biotechnologies, Inc Main Business
7.9.3 ProMab Biotechnologies, Inc CAR-T Cell Service Products, Services and Solutions
7.9.4 ProMab Biotechnologies, Inc CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.9.5 ProMab Biotechnologies, Inc Recent Developments
7.10 Creative Biogene
7.10.1 Creative Biogene Profile
7.10.2 Creative Biogene Main Business
7.10.3 Creative Biogene CAR-T Cell Service Products, Services and Solutions
7.10.4 Creative Biogene CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.10.5 Creative Biogene Recent Developments
7.11 BPS Bioscience, Inc
7.11.1 BPS Bioscience, Inc Profile
7.11.2 BPS Bioscience, Inc Main Business
7.11.3 BPS Bioscience, Inc CAR-T Cell Service Products, Services and Solutions
7.11.4 BPS Bioscience, Inc CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.11.5 BPS Bioscience, Inc Recent Developments
7.12 Reaction Biology
7.12.1 Reaction Biology Profile
7.12.2 Reaction Biology Main Business
7.12.3 Reaction Biology CAR-T Cell Service Products, Services and Solutions
7.12.4 Reaction Biology CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.12.5 Reaction Biology Recent Developments
7.13 Cusabio Technology LLC
7.13.1 Cusabio Technology LLC Profile
7.13.2 Cusabio Technology LLC Main Business
7.13.3 Cusabio Technology LLC CAR-T Cell Service Products, Services and Solutions
7.13.4 Cusabio Technology LLC CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.13.5 Cusabio Technology LLC Recent Developments
7.14 Oncodesign Services
7.14.1 Oncodesign Services Profile
7.14.2 Oncodesign Services Main Business
7.14.3 Oncodesign Services CAR-T Cell Service Products, Services and Solutions
7.14.4 Oncodesign Services CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.14.5 Oncodesign Services Recent Developments
7.15 ACROBiosystems
7.15.1 ACROBiosystems Profile
7.15.2 ACROBiosystems Main Business
7.15.3 ACROBiosystems CAR-T Cell Service Products, Services and Solutions
7.15.4 ACROBiosystems CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.15.5 ACROBiosystems Recent Developments
7.16 Kite Pharma, Inc
7.16.1 Kite Pharma, Inc Profile
7.16.2 Kite Pharma, Inc Main Business
7.16.3 Kite Pharma, Inc CAR-T Cell Service Products, Services and Solutions
7.16.4 Kite Pharma, Inc CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.16.5 Kite Pharma, Inc Recent Developments
7.17 sartorius
7.17.1 sartorius Profile
7.17.2 sartorius Main Business
7.17.3 sartorius CAR-T Cell Service Products, Services and Solutions
7.17.4 sartorius CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.17.5 sartorius Recent Developments
7.18 WuXi ATU Co
7.18.1 WuXi ATU Co Profile
7.18.2 WuXi ATU Co Main Business
7.18.3 WuXi ATU Co CAR-T Cell Service Products, Services and Solutions
7.18.4 WuXi ATU Co CAR-T Cell Service Revenue (US$ Million) & (2020-2025)
7.18.5 WuXi ATU Co Recent Developments
8 Industry Chain Analysis
8.1 CAR-T Cell Service Industrial Chain
8.2 CAR-T Cell Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 CAR-T Cell Service Sales Model
8.5.2 Sales Channel
8.5.3 CAR-T Cell Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. CAR-T Cell Service Market Trends
Table 2. CAR-T Cell Service Market Drivers & Opportunity
Table 3. CAR-T Cell Service Market Challenges
Table 4. CAR-T Cell Service Market Restraints
Table 5. Global CAR-T Cell Service Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global CAR-T Cell Service Revenue Market Share by Company (2020-2025)
Table 7. Key Companies CAR-T Cell Service Manufacturing Base Distribution and Headquarters
Table 8. Key Companies CAR-T Cell Service Product Type
Table 9. Key Companies Time to Begin Mass Production of CAR-T Cell Service
Table 10. Global CAR-T Cell Service Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Cell Service as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global CAR-T Cell Service Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global CAR-T Cell Service Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global CAR-T Cell Service Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global CAR-T Cell Service Sales Market Share in Value by Type (2020-2025)
Table 17. Global CAR-T Cell Service Sales Market Share in Value by Type (2026-2031)
Table 18. Global CAR-T Cell Service Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global CAR-T Cell Service Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global CAR-T Cell Service Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global CAR-T Cell Service Sales Market Share in Value by Application (2020-2025)
Table 22. Global CAR-T Cell Service Sales Market Share in Value by Application (2026-2031)
Table 23. Global CAR-T Cell Service Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global CAR-T Cell Service Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global CAR-T Cell Service Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global CAR-T Cell Service Sales Value by Region (2020-2025) & (%)
Table 27. Global CAR-T Cell Service Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions CAR-T Cell Service Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions CAR-T Cell Service Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions CAR-T Cell Service Sales Value, (2026-2031) & (US$ Million)
Table 31. Aurigene Pharmaceutical Services Ltd Basic Information List
Table 32. Aurigene Pharmaceutical Services Ltd Description and Business Overview
Table 33. Aurigene Pharmaceutical Services Ltd CAR-T Cell Service Products, Services and Solutions
Table 34. Revenue (US$ Million) in CAR-T Cell Service Business of Aurigene Pharmaceutical Services Ltd (2020-2025)
Table 35. Aurigene Pharmaceutical Services Ltd Recent Developments
Table 36. Cellipont Bioservices Basic Information List
Table 37. Cellipont Bioservices Description and Business Overview
Table 38. Cellipont Bioservices CAR-T Cell Service Products, Services and Solutions
Table 39. Revenue (US$ Million) in CAR-T Cell Service Business of Cellipont Bioservices (2020-2025)
Table 40. Cellipont Bioservices Recent Developments
Table 41. ProBio Basic Information List
Table 42. ProBio Description and Business Overview
Table 43. ProBio CAR-T Cell Service Products, Services and Solutions
Table 44. Revenue (US$ Million) in CAR-T Cell Service Business of ProBio (2020-2025)
Table 45. ProBio Recent Developments
Table 46. Creative Biolabs Basic Information List
Table 47. Creative Biolabs Description and Business Overview
Table 48. Creative Biolabs CAR-T Cell Service Products, Services and Solutions
Table 49. Revenue (US$ Million) in CAR-T Cell Service Business of Creative Biolabs (2020-2025)
Table 50. Creative Biolabs Recent Developments
Table 51. Charles River Laboratories Basic Information List
Table 52. Charles River Laboratories Description and Business Overview
Table 53. Charles River Laboratories CAR-T Cell Service Products, Services and Solutions
Table 54. Revenue (US$ Million) in CAR-T Cell Service Business of Charles River Laboratories (2020-2025)
Table 55. Charles River Laboratories Recent Developments
Table 56. Cytiva Basic Information List
Table 57. Cytiva Description and Business Overview
Table 58. Cytiva CAR-T Cell Service Products, Services and Solutions
Table 59. Revenue (US$ Million) in CAR-T Cell Service Business of Cytiva (2020-2025)
Table 60. Cytiva Recent Developments
Table 61. Sino Biological, Inc Basic Information List
Table 62. Sino Biological, Inc Description and Business Overview
Table 63. Sino Biological, Inc CAR-T Cell Service Products, Services and Solutions
Table 64. Revenue (US$ Million) in CAR-T Cell Service Business of Sino Biological, Inc (2020-2025)
Table 65. Sino Biological, Inc Recent Developments
Table 66. Miltenyi Biotec Basic Information List
Table 67. Miltenyi Biotec Description and Business Overview
Table 68. Miltenyi Biotec CAR-T Cell Service Products, Services and Solutions
Table 69. Revenue (US$ Million) in CAR-T Cell Service Business of Miltenyi Biotec (2020-2025)
Table 70. Miltenyi Biotec Recent Developments
Table 71. ProMab Biotechnologies, Inc Basic Information List
Table 72. ProMab Biotechnologies, Inc Description and Business Overview
Table 73. ProMab Biotechnologies, Inc CAR-T Cell Service Products, Services and Solutions
Table 74. Revenue (US$ Million) in CAR-T Cell Service Business of ProMab Biotechnologies, Inc (2020-2025)
Table 75. ProMab Biotechnologies, Inc Recent Developments
Table 76. Creative Biogene Basic Information List
Table 77. Creative Biogene Description and Business Overview
Table 78. Creative Biogene CAR-T Cell Service Products, Services and Solutions
Table 79. Revenue (US$ Million) in CAR-T Cell Service Business of Creative Biogene (2020-2025)
Table 80. Creative Biogene Recent Developments
Table 81. BPS Bioscience, Inc Basic Information List
Table 82. BPS Bioscience, Inc Description and Business Overview
Table 83. BPS Bioscience, Inc CAR-T Cell Service Products, Services and Solutions
Table 84. Revenue (US$ Million) in CAR-T Cell Service Business of BPS Bioscience, Inc (2020-2025)
Table 85. BPS Bioscience, Inc Recent Developments
Table 86. Reaction Biology Basic Information List
Table 87. Reaction Biology Description and Business Overview
Table 88. Reaction Biology CAR-T Cell Service Products, Services and Solutions
Table 89. Revenue (US$ Million) in CAR-T Cell Service Business of Reaction Biology (2020-2025)
Table 90. Reaction Biology Recent Developments
Table 91. Cusabio Technology LLC Basic Information List
Table 92. Cusabio Technology LLC Description and Business Overview
Table 93. Cusabio Technology LLC CAR-T Cell Service Products, Services and Solutions
Table 94. Revenue (US$ Million) in CAR-T Cell Service Business of Cusabio Technology LLC (2020-2025)
Table 95. Cusabio Technology LLC Recent Developments
Table 96. Oncodesign Services Basic Information List
Table 97. Oncodesign Services Description and Business Overview
Table 98. Oncodesign Services CAR-T Cell Service Products, Services and Solutions
Table 99. Revenue (US$ Million) in CAR-T Cell Service Business of Oncodesign Services (2020-2025)
Table 100. Oncodesign Services Recent Developments
Table 101. ACROBiosystems Basic Information List
Table 102. ACROBiosystems Description and Business Overview
Table 103. ACROBiosystems CAR-T Cell Service Products, Services and Solutions
Table 104. Revenue (US$ Million) in CAR-T Cell Service Business of ACROBiosystems (2020-2025)
Table 105. ACROBiosystems Recent Developments
Table 106. Kite Pharma, Inc Basic Information List
Table 107. Kite Pharma, Inc Description and Business Overview
Table 108. Kite Pharma, Inc CAR-T Cell Service Products, Services and Solutions
Table 109. Revenue (US$ Million) in CAR-T Cell Service Business of Kite Pharma, Inc (2020-2025)
Table 110. Kite Pharma, Inc Recent Developments
Table 111. sartorius Basic Information List
Table 112. sartorius Description and Business Overview
Table 113. sartorius CAR-T Cell Service Products, Services and Solutions
Table 114. Revenue (US$ Million) in CAR-T Cell Service Business of sartorius (2020-2025)
Table 115. sartorius Recent Developments
Table 116. WuXi ATU Co Basic Information List
Table 117. WuXi ATU Co Description and Business Overview
Table 118. WuXi ATU Co CAR-T Cell Service Products, Services and Solutions
Table 119. Revenue (US$ Million) in CAR-T Cell Service Business of WuXi ATU Co (2020-2025)
Table 120. WuXi ATU Co Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. CAR-T Cell Service Downstream Customers
Table 124. CAR-T Cell Service Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. CAR-T Cell Service Product Picture
Figure 2. Global CAR-T Cell Service Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global CAR-T Cell Service Sales Value (2020-2031) & (US$ Million)
Figure 4. CAR-T Cell Service Report Years Considered
Figure 5. Global CAR-T Cell Service Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by CAR-T Cell Service Revenue in 2024
Figure 7. CAR-T Cell Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Development Services Picture
Figure 9. Manufacturing Services Picture
Figure 10. Other Picture
Figure 11. Global CAR-T Cell Service Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global CAR-T Cell Service Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Clinical Research
Figure 14. Product Picture of Clinical Treatment
Figure 15. Product Picture of Other
Figure 16. Global CAR-T Cell Service Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 17. Global CAR-T Cell Service Sales Value Market Share by Application, 2024 & 2031
Figure 18. North America CAR-T Cell Service Sales Value (2020-2031) & (US$ Million)
Figure 19. North America CAR-T Cell Service Sales Value by Country (%), 2024 VS 2031
Figure 20. Europe CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 21. Europe CAR-T Cell Service Sales Value by Country (%), 2024 VS 2031
Figure 22. Asia Pacific CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 23. Asia Pacific CAR-T Cell Service Sales Value by Region (%), 2024 VS 2031
Figure 24. South America CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 25. South America CAR-T Cell Service Sales Value by Country (%), 2024 VS 2031
Figure 26. Middle East & Africa CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 27. Middle East & Africa CAR-T Cell Service Sales Value by Country (%), 2024 VS 2031
Figure 28. Key Countries/Regions CAR-T Cell Service Sales Value (%), (2020-2031)
Figure 29. United States CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 30. United States CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
Figure 31. United States CAR-T Cell Service Sales Value by Application (%), 2024 VS 2031
Figure 32. Europe CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
Figure 34. Europe CAR-T Cell Service Sales Value by Application (%), 2024 VS 2031
Figure 35. China CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 36. China CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
Figure 37. China CAR-T Cell Service Sales Value by Application (%), 2024 VS 2031
Figure 38. Japan CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 39. Japan CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
Figure 40. Japan CAR-T Cell Service Sales Value by Application (%), 2024 VS 2031
Figure 41. South Korea CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 42. South Korea CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
Figure 43. South Korea CAR-T Cell Service Sales Value by Application (%), 2024 VS 2031
Figure 44. Southeast Asia CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 45. Southeast Asia CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
Figure 46. Southeast Asia CAR-T Cell Service Sales Value by Application (%), 2024 VS 2031
Figure 47. India CAR-T Cell Service Sales Value, (2020-2031) & (US$ Million)
Figure 48. India CAR-T Cell Service Sales Value by Type (%), 2024 VS 2031
Figure 49. India CAR-T Cell Service Sales Value by Application (%), 2024 VS 2031
Figure 50. CAR-T Cell Service Industrial Chain
Figure 51. CAR-T Cell Service Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global CAR-T Cell Service market?
The top companies in the global CAR-T Cell Service market are Aurigene Pharmaceutical Services Ltd、Cellipont Bioservices、ProBio.
What is the annual compound growth rate of the global CAR-T Cell Service market size from 2025 to 2031?
What was the global market size of CAR-T Cell Service in 2025?
Which region is expected to have the highest market share?
What was the global market size of CAR-T Cell Service in 2031?
Related Reports
Global CAR-T Cell Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global CAR-T Cell Service market is projected to grow from US$ 1443 million in 2025 to US$ 2075 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 147
USD 4900.00
(Single User License)
Global CAR-T Cell Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global CAR-T Cell Service market size was US$ 1443 million in 2025 and is forecast to reach a readjusted size of US$ 2075 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 102
USD 4250.00
(Single User License)
CAR-T Cell Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for CAR-T Cell Service was estimated to be worth US$ 1443 million in 2025 and is projected to reach US$ 2075 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 132
USD 3950.00
(Single User License)
Global CAR-T Cell Service Market Research Report 2026
The global CAR-T Cell Service market was valued at US$ 1443 million in 2025 and is anticipated to reach US$ 2075 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 137
USD 2900.00
(Single User License)
Global CAR-T Cell Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global CAR-T Cell Service market size was US$ 1375 million in 2024 and is forecast to a readjusted size of US$ 1978 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 102
USD 4250.00
(Single User License)
Global CAR-T Cell Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global CAR-T Cell Service market is projected to grow from US$ 1375 million in 2024 to US$ 1978 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 147
USD 4900.00
(Single User License)
Global CAR-T Cell Service Market Insights, Forecast to 2031
The global CAR-T Cell Service market is projected to grow from US$ 1443 million in 2025 to US$ 1978 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Published Date: 2025-04-03
Pages: 160
USD 4900.00
(Single User License)
Global CAR-T Cell Service Market Research Report 2025
The global market for CAR-T Cell Service was valued at US$ 1375 million in the year 2024 and is projected to reach a revised size of US$ 1978 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published Date: 2025-04-03
Pages: 98
USD 2900.00
(Single User License)
Global CAR-T Cell Service Market Research Report 2024
CAR-T (Chimeric Antigen Receptor T-cell) therapy is an innovative and personalized form of immunotherapy designed to treat certain types of cancers, particularly blood cancers like leukemia and lymphoma. The development of CAR-T cells involves a complex process that requires several specialized services. A comprehensive CAR-T cell development service covers the entire pipeline from initial consultation and CAR design through to clinical trials and post-approval support. It is tailored to meet the unique needs of each patient's cancer type, the desired target antigen, and the specific requirements of regulatory agencies.
Published Date: 2024-09-12
Pages: 97
USD 2900.00
(Single User License)
Global and United States CAR-T Cell Service Market Report & Forecast 2024-2030
CAR-T (Chimeric Antigen Receptor T-cell) therapy is an innovative and personalized form of immunotherapy designed to treat certain types of cancers, particularly blood cancers like leukemia and lymphoma. The development of CAR-T cells involves a complex process that requires several specialized services. A comprehensive CAR-T cell development service covers the entire pipeline from initial consultation and CAR design through to clinical trials and post-approval support. It is tailored to meet the unique needs of each patient's cancer type, the desired target antigen, and the specific requirements of regulatory agencies.
Published Date: 2024-09-12
Pages: 130
USD 4350.00
(Single User License)
Global CAR-T Cell Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global CAR-T Cell Service market is projected to grow from US$ 1443 million in 2025 to US$ 2075 million by 2032, at a CAGR of 5.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 147
USD 4900.00 (Single User License)Global CAR-T Cell Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global CAR-T Cell Service market size was US$ 1443 million in 2025 and is forecast to reach a readjusted size of US$ 2075 million by 2032 with a CAGR of 5.4% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 102
USD 4250.00 (Single User License)CAR-T Cell Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for CAR-T Cell Service was estimated to be worth US$ 1443 million in 2025 and is projected to reach US$ 2075 million, growing at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-09
Pages: 132
USD 3950.00 (Single User License)Global CAR-T Cell Service Market Research Report 2026
The global CAR-T Cell Service market was valued at US$ 1443 million in 2025 and is anticipated to reach US$ 2075 million by 2032, at a CAGR of 5.4% from 2026 to 2032.
Published: 2026-01-09
Pages: 137
USD 2900.00 (Single User License)Global CAR-T Cell Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global CAR-T Cell Service market size was US$ 1375 million in 2024 and is forecast to a readjusted size of US$ 1978 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 102
USD 4250.00 (Single User License)Global CAR-T Cell Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global CAR-T Cell Service market is projected to grow from US$ 1375 million in 2024 to US$ 1978 million by 2031, at a CAGR of 5.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 147
USD 4900.00 (Single User License)Global CAR-T Cell Service Market Insights, Forecast to 2031
The global CAR-T Cell Service market is projected to grow from US$ 1443 million in 2025 to US$ 1978 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.
Published: 2025-04-03
Pages: 160
USD 4900.00 (Single User License)Global CAR-T Cell Service Market Research Report 2025
The global market for CAR-T Cell Service was valued at US$ 1375 million in the year 2024 and is projected to reach a revised size of US$ 1978 million by 2031, growing at a CAGR of 5.4% during the forecast period.
Published: 2025-04-03
Pages: 98
USD 2900.00 (Single User License)Global CAR-T Cell Service Market Research Report 2024
CAR-T (Chimeric Antigen Receptor T-cell) therapy is an innovative and personalized form of immunotherapy designed to treat certain types of cancers, particularly blood cancers like leukemia and lymphoma. The development of CAR-T cells involves a complex process that requires several specialized services. A comprehensive CAR-T cell development service covers the entire pipeline from initial consultation and CAR design through to clinical trials and post-approval support. It is tailored to meet the unique needs of each patient's cancer type, the desired target antigen, and the specific requirements of regulatory agencies.
Published: 2024-09-12
Pages: 97
USD 2900.00 (Single User License)Global and United States CAR-T Cell Service Market Report & Forecast 2024-2030
CAR-T (Chimeric Antigen Receptor T-cell) therapy is an innovative and personalized form of immunotherapy designed to treat certain types of cancers, particularly blood cancers like leukemia and lymphoma. The development of CAR-T cells involves a complex process that requires several specialized services. A comprehensive CAR-T cell development service covers the entire pipeline from initial consultation and CAR design through to clinical trials and post-approval support. It is tailored to meet the unique needs of each patient's cancer type, the desired target antigen, and the specific requirements of regulatory agencies.
Published: 2024-09-12
Pages: 130
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now